So, Monday morning is off to a rough start. U.S. stock futures are deep in the red, following a down day on Friday. The culprit? A historic surge in oil prices, with Brent crude spiking 14.90% to $106.50 and WTI surging 13.27% to $102.96. Both benchmarks are now aggressively testing their 52-week highs, all thanks to the escalating conflict between the U.S. and Iran.
It's a classic market bloodbath, but not everyone is hitting the panic button. President Donald Trump took to Truth Social to frame the record-high fuel costs as a necessary, and temporary, byproduct of his administration's offensive against Tehran. The economic anxiety, in his view, is just a "short term" spike.
Meanwhile, the bond market is relatively calm. The 10-year Treasury yield is at 4.19%, and the two-year is at 3.63%. According to the CME Group's FedWatch tool, markets are pricing in a 97.3% chance the Federal Reserve leaves interest rates unchanged at its March meeting. So, for now, the focus is squarely on geopolitics, not monetary policy.
Here’s how the major indices were shaping up in premarket trading:
| Index | Performance (+/-) |
| Dow Jones | -1.61% |
| S&P 500 | -1.41% |
| Nasdaq 100 | -1.56% |
| Russell 2000 | -2.60% |
The ETFs tracking the broad market were feeling the pain too. The SPDR S&P 500 ETF Trust (SPY) was down 1.21% at $664.25, and the Invesco QQQ Trust ETF (QQQ) declined 1.38% to $591.49.
Stocks in Focus: The Movers and Shakers
Even in a sea of red, some individual stocks are making huge moves on their own news.
Ovintiv
Ovintiv Inc. (OVV) jumped 5.24% in premarket trading. The move came after a Form 4 filing showed Director Mayson Howard John sold 5,000 shares of common stock last week. Despite the insider sale, market data indicates OVV maintains a strong price trend across short, medium, and long-term timeframes with a solid value ranking.
Hims & Hers Health
This was the big winner of the morning. Hims & Hers Health Inc. (HIMS) surged a staggering 49.36%. The catalyst? The company reportedly ended a public feud with Novo Nordisk AS (NVO) and will now sell Novo's weight-loss drug on its telehealth platform. It's a major business development, though market data suggests HIMS has shown a weaker price trend over various timeframes with a moderate growth ranking.
Uniqure
Uniqure NV (QURE) rocketed 35.88% higher, fueled by what looks like a high-stakes short squeeze. The move followed clarification from a senior FDA official that the regulatory path for its Huntington's disease therapy, AMT-130, is less invasive than investors had feared. Despite the pop, data shows QURE has maintained a weak price trend in the long, short, and medium terms.
Starfighters Space
Not every stock was celebrating. Starfighters Space Inc. (FJET) dropped 3.86%. The decline came as analysts at Rothschild & Co Redburn highlighted that the Middle East conflict poses a major "obstacle for airline carriers, as it could drive jet fuel prices higher." Market data indicates FJET has a weaker price trend across all measured timeframes.
Casey's General Stores
Casey's General Stores Inc. (CASY) was down a modest 0.94% ahead of its earnings report after the closing bell. Analysts expect the company to report earnings of $2.98 per share on revenue of $4.04 billion. Data shows CASY maintains a strong price trend with a solid quality score.
Cues From the Last Session
Friday's session set the stage for today's decline. While the major indices all closed lower, there was a split beneath the surface. Energy and consumer staples stocks actually bucked the trend and finished higher. The biggest losses were in consumer discretionary, materials, and information technology sectors.
| Index | Performance (+/-) | Value |
| Dow Jones | -0.95% | 47,501.55 |
| S&P 500 | -1.33% | 6,740.02 |
| Nasdaq Composite | -1.59% | 22,387.68 |
| Russell 2000 | -2.33% | 2,525.30 |













